טוען...
Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture
BACKGROUND: Mortality is increased after a hip fracture, and strategies that improve outcomes are needed. METHODS: In this randomized, double-blind, placebo-controlled trial, 1065 patients were assigned to receive yearly intravenous zoledronic acid (at a dose of 5 mg), and 1062 patients were assigne...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2324066/ https://ncbi.nlm.nih.gov/pubmed/17878149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa074941 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|